Jacklynn V Egger
8PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 18, 2025
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.Federica Pecci, Rohit Thummalapalli, Stephanie L Alden
|Jul 06, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.Christopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin
|Jun 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.Adam J Schoenfeld, Hira A Rizvi, Danish Memon
|Nov 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy.Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao
|Jul 10, 2021
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer.Jia Luo, Victoria L Martucci, Zoe Quandt
|Jun 22, 2021
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation.Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan
Pageof 2
Frequent Collaborators
5 joint publications
Matthew Hellmann
4 joint publications
Charles M Rudin
3 joint publications
Adam J Schoenfeld
3 joint publications
Natasha Rekhtman
3 joint publications
Michael Offin
2 joint publications
Jia Luo
2 joint publications
Jennifer L Sauter
2 joint publications
John T Poirier
2 joint publications
Yingqian A Zhan
2 joint publications
Metamia Ciampricotti
